Immuron Ltd
IMRN · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Form 20-F
SEC filing · Filed
-
Palumbo Flavio: Form 3
Insider disclosure · Filed · Report period 18 Mar 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- IMRN · 45254U101 - SPONSORED ADR
Company details and SEC sources
CIK 0001660046 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IMRN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 62 Lygon Street, Level 3, Carlton, Victoria, Australia, 3053
- Incorporated in
- Australia
- Fiscal year end
- 30 June
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields